VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE

VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE

Show other versions (1)

Okavax is the first vaccine (based on strain Oka) against varicella in the world. It has high immunogenicity, provides maximally prolonged defence due to forming of cell immunity. Thus, Okavax is efficient against severe varicella. Efficiency of this vaccine is confirmed with results of studies duri...

Full description

Bibliographic Details
Main Author: M.G. Galitskaya
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-09-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:https://vsp.spr-journal.ru/jour/article/view/957
id doaj-b4076dfd00144d679cdb66913064ff45
record_format Article
spelling doaj-b4076dfd00144d679cdb66913064ff452021-07-28T21:15:37Zeng"Paediatrician" Publishers LLC Voprosy Sovremennoj Pediatrii1682-55271682-55352010-09-019599102958VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICEM.G. Galitskaya0Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowOkavax is the first vaccine (based on strain Oka) against varicella in the world. It has high immunogenicity, provides maximally prolonged defence due to forming of cell immunity. Thus, Okavax is efficient against severe varicella. Efficiency of this vaccine is confirmed with results of studies during 20 years. Okavax has good tolerability; it can be recommended to all patients after 12 months old, especially to patients from risk groups. Key words: children, varicella, vaccination.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):99-102)https://vsp.spr-journal.ru/jour/article/view/957
collection DOAJ
language English
format Article
sources DOAJ
author M.G. Galitskaya
spellingShingle M.G. Galitskaya
VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
Voprosy Sovremennoj Pediatrii
author_facet M.G. Galitskaya
author_sort M.G. Galitskaya
title VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
title_short VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
title_full VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
title_fullStr VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
title_full_unstemmed VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
title_sort varicella: opportunities of fighting with «old enemy» in pediatric practice
publisher "Paediatrician" Publishers LLC
series Voprosy Sovremennoj Pediatrii
issn 1682-5527
1682-5535
publishDate 2010-09-01
description Okavax is the first vaccine (based on strain Oka) against varicella in the world. It has high immunogenicity, provides maximally prolonged defence due to forming of cell immunity. Thus, Okavax is efficient against severe varicella. Efficiency of this vaccine is confirmed with results of studies during 20 years. Okavax has good tolerability; it can be recommended to all patients after 12 months old, especially to patients from risk groups. Key words: children, varicella, vaccination.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):99-102)
url https://vsp.spr-journal.ru/jour/article/view/957
work_keys_str_mv AT mggalitskaya varicellaopportunitiesoffightingwitholdenemyinpediatricpractice
_version_ 1721261518940536832

Similar Items